tiprankstipranks
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF

ONO Pharmaceutical Co (OPHLF) Financial Statements

14 Followers

ONO Pharmaceutical Co Financial Overview

ONO Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $1.86; its P/E ratio is 8.18; and it has a dividend yield of 3.59%. ONO Pharmaceutical Co is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 122.32B-¥ 106.72B¥ 89.93B¥ 97.35B
Gross Profit¥ 92.24B-¥ 79.78B¥ 67.05B¥ 72.28B
EBIT¥ 43.51B-¥ 39.32B¥ 21.20B¥ 24.00B
EBITDA¥ 47.83B-¥ 43.62B¥ 25.83B¥ 28.39B
Net Income Common Stockholders¥ 33.32B-¥ 29.48B¥ 15.90B¥ 18.33B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 177.03B¥ 0.00¥ 136.18B¥ 116.97B¥ 110.25B
Total Assets¥ 830.54B-¥ 764.19B¥ 739.20B¥ 740.06B
Total Debt¥ 8.90B¥ 0.00¥ 8.65B¥ 8.80B¥ 9.10B
Net Debt¥ -168.14B¥ 0.00¥ -127.53B¥ -108.17B¥ -101.16B
Total Liabilities--¥ 86.48B¥ 77.53B¥ 73.73B
Stockholders Equity¥ 721.38B¥ 0.00¥ 671.89B¥ 655.91B¥ 660.67B
Cash Flow-
Free Cash Flow¥ 29.45B-¥ 29.30B¥ 32.37B¥ -14.56B
Operating Cash Flow¥ 34.09B-¥ 33.08B¥ 34.43B¥ -12.97B
Investing Cash Flow¥ -6.93B-¥ -1.32B¥ -12.02B¥ 23.44B
Financing Cash Flow¥ -15.81B-¥ -13.36B¥ -16.00B¥ -29.27B
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

ONO Pharmaceutical Co Debt to Assets

ONO Pharmaceutical Co Cash Flow

ONO Pharmaceutical Co Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis